RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cells

RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cells

Triple-negative breast cancer (TNBC) stands out as the most aggressive subtype within the spectrum of breast cancer. The current clinical guidelines propose treatment strategies involving cytotoxic agents like epirubicin or paclitaxel. However, the emergence of acquired resistance frequently precipi...

書誌詳細
主要な著者:	Fengxu Lv, Wentao Si, Xiaodan Xu, Xiaogang He, Ying Wang, Yetian Li, Feifei Li
フォーマット:	論文
言語:	English
出版事項:	Elsevier 2024-02-01
シリーズ:	Neoplasia: An International Journal for Oncology Research
主題:	Triple negative breast cancer Chemoresistance Cancer stem cells RUNX2 TGF-β
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S1476558624000046

類似資料

RUNX2 facilitates aggressiveness and chemoresistance of triple negative breast cancer cells via activating MMP1
著者:: Wentao Si, 等
出版事項: (2022-11-01)

RUNX1 Is Regulated by Androgen Receptor to Promote Cancer Stem Markers and Chemotherapy Resistance in Triple Negative Breast Cancer
著者:: Natalia B. Fernández, 等
出版事項: (2023-01-01)

Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers
著者:: Bradley A. Hancock, 等
出版事項: (2019-08-01)

Comprehensive Analysis of RUNX and TGF-β Mediated Regulation of Immune Cell Infiltration in Breast Cancer
著者:: Liang Gao, 等
出版事項: (2021-08-01)

TGF-β induced reprogramming and drug resistance in triple-negative breast cells
著者:: Guoyu Wu, 等
出版事項: (2022-04-01)

CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death
著者:: Alexander H. Chung, 等
出版事項: (2019-02-01)

DNA methylation affects metastasis of renal cancer and is associated with TGF-β/RUNX3 inhibition
著者:: Jianbo Zheng, 等
出版事項: (2018-04-01)

Atractylenolide-I Sensitizes Triple-Negative Breast Cancer Cells to Paclitaxel by Blocking CTGF Expression and Fibroblast Activation
著者:: Meng Wang, 等
出版事項: (2021-10-01)

Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers
著者:: Anuradha Illendula, 等
出版事項: (2016-06-01)

Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model
著者:: Margarite D. Matossian, 等
出版事項: (2019-03-01)

Data mining analysis of miR-638 and key genes interaction in cisplatin resistant triple-negative breast cancer
著者:: Adam Hermawan, 等
出版事項: (2019-12-01)

The RUNX/CBFβ Complex in Breast Cancer: A Conundrum of Context
著者:: Adiba S. Khan, 等
出版事項: (2023-02-01)

Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer
著者:: Shen-Jun Yuan, 等
出版事項: (2019-10-01)

B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
著者:: Ling Wang, 等
出版事項: (2018-07-01)

A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer
著者:: Hitesh Kumar, 等
出版事項: (2023-12-01)

miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A
著者:: Liu C, 等
出版事項: (2020-12-01)

A clinicopathologic study of triple negative breast cancer
著者:: Vandana L Gaopande, 等
出版事項: (2015-01-01)

IL-17A Increases Doxorubicin Efficacy in Triple Negative Breast Cancer
著者:: Nicholas R. Hum, 等
出版事項: (2022-07-01)

Clinically Translatable Approaches of Inhibiting TGF-β to Target Cancer Stem Cells in TNBC
著者:: Andrew Sulaiman, 等
出版事項: (2021-10-01)

CXCR2 Small-Molecule Antagonist Combats Chemoresistance and Enhances Immunotherapy in Triple-Negative Breast Cancer
著者:: Alaa M. Ghallab, 等
出版事項: (2022-04-01)

Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer
著者:: Lei Di, 等
出版事項: (2019-03-01)

TUFT1 promotes metastasis and chemoresistance in triple negative breast cancer through the TUFT1/Rab5/Rac1 pathway
著者:: Weiguang Liu, 等
出版事項: (2019-09-01)

RUNX regulated immune-associated genes predicts prognosis in breast cancer
著者:: Jingyue Fu, 等
出版事項: (2022-08-01)

M6A demethylase ALKBH5 regulates FOXO1 mRNA stability and chemoresistance in triple-negative breast cancer
著者:: Xi Liu, 等
出版事項: (2024-02-01)

CD74-AKT Axis Is a Potential Therapeutic Target in Triple-Negative Breast Cancer
著者:: Jingchao Wang, 等
出版事項: (2024-06-01)

Role of eIF4A1 in triple‐negative breast cancer stem‐like cell‐mediated drug resistance
著者:: Dayanidhi Raman, 等
出版事項: (2022-12-01)

Cyclodextrin Diethyldithiocarbamate Copper II Inclusion Complexes: A Promising Chemotherapeutic Delivery System against Chemoresistant Triple Negative Breast Cancer Cell Lines
著者:: Ammar Said Suliman, 等
出版事項: (2021-01-01)

Kinome-Wide siRNA Screening Identifies Src-Enhanced Resistance of Chemotherapeutic Drugs in Triple-Negative Breast Cancer Cells
著者:: Yen-Dun Tony Tzeng, 等
出版事項: (2018-11-01)

TUFT1 Promotes Triple Negative Breast Cancer Metastasis, Stemness, and Chemoresistance by Up-Regulating the Rac1/β-Catenin Pathway
著者:: Weiguang Liu, 等
出版事項: (2019-07-01)

Current approaches in treatment of triple-negative breast cancer
著者:: Hanan Ahmed Wahba, 等
出版事項: (2015-06-01)

Triple-Negative Breast Cancer Survival in Iranian Patients
著者:: Mahdi Aghili, 等
出版事項: (2013-08-01)

Platinum chemotherapy for early triple-negative breast cancer
著者:: Sofia RE. Mason, 等
出版事項: (2024-06-01)

Does triple negative breast cancer subtype carry poorer prognosis as compared to non-triple negative breast cancer lesion - A study from a tertiary hospital
著者:: Srijan Basu, 等
出版事項: (2023-11-01)

Is breast conservation superior to mastectomy in early stage triple negative breast cancer?
著者:: Omran Saifi, 等
出版事項: (2022-04-01)

USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1
著者:: Yueh-Te Lin, 等
出版事項: (2022-10-01)

Immunotherapy Treatment for Triple Negative Breast Cancer
著者:: Elizabeth R. Berger, 等
出版事項: (2021-08-01)

Immunohistochemical evaluation of osteopontin expression in triple-negative breast cancer
著者:: Magdalena Niedolistek, 等
出版事項: (2020-04-01)

Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells
著者:: Lisa Agnello, 等
出版事項: (2023-07-01)

Metastatic Triple Negative Breast Cancer: The New Era of Thinking
著者:: Mohammed Amrallah A., 等
出版事項: (2021-05-01)

The Adipokine Visfatin Modulates Cancer Stem Cell Properties in Triple-Negative Breast Cancer
著者:: Yi-Fen Chiang, 等
出版事項: (2023-01-01)